Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
Chunyan Lu,1 Yun Chen,2 Bin Zhang,2 Yu Chen,2 Fan Bai,2 Decai Chen1 1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China; 2Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China Abstract: Teriparatide is the first anabolic agent for osteoporosis, and t...
Enregistré dans:
Auteurs principaux: | Lu C, Chen Y, Zhang B, Bai F, Chen D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b9ac0f2e0dc640189aaaabb618b28cfd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment of osteoporosis with teriparatide: The Slovenian experience
par: Kocjan Tomaz, et autres
Publié: (2021) -
Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
par: Xie Z, et autres
Publié: (2019) -
Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study
par: Nishikawa A, et autres
Publié: (2016) -
Serum uric acid is associated with lumbar spine bone mineral density in healthy Chinese males older than 50 years
par: Xiao J, et autres
Publié: (2017) -
The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
par: Wang Z, et autres
Publié: (2021)